Does JellyFil Have Side Effects? The Nine Plants, One at a Time

Nothing in the JellyFil blend is exotic and the amounts are small, so the useful safety conversation is about three specific things rather than a general caution: the PDE5 question raised by horny goat weed, the liver signals attached to green tea extract and ashwagandha, and the caffeine and sugar the panel declares.

Plant by plant, then the three that matter, then the label's own warning reproduced in full.

The short list

The three JellyFil questions worth taking seriously

The enzyme question

Horny goat weed is on the panel. Its isolated compound inhibits human PDE5, the enzyme nitrates interact with and erectile-dysfunction prescriptions block. The combination has not been measured at these amounts. Raise it with a clinician by name before starting.

The liver question

Green tea extract carries a US Pharmacopeia hepatotoxicity review and a recommended cautionary statement. Ashwagandha has case series from Iceland and the United States and from India. A national survey put both among six botanicals 15.6 million US adults had taken in a month.

The declared caffeine

5 mg a gummy. Too small to disturb most people's sleep, and still five milligrams that were not on your list. If you are caffeine-sensitive or already at your ceiling, count it.

The declared sugar

3 g of added sugar and 10 calories a day, 6% of the Daily Value. Negligible for most people and a line on the panel for anyone managing blood sugar.

Plant by plant

Each plant in JellyFil, and what is known about tolerating it

Plant	What is reported	Worth knowing
Muira puama	Little in the human record either way	The review of herbal sexual enhancers covers it among plants with occasional psychiatric and neurological reports
Maca	Well tolerated in the trials, including at 3 g a day for twelve weeks	The 175-person safety trial is the largest tolerance dataset here
Catuaba	Human tolerance data is thin	Mostly animal work, and the species behind the common name is not stated on this panel
Green tea extract	A recognised, uncommon liver signal	The USP review is why a cautionary statement is recommended on products carrying it
Caffeine	Dose-dependent and well characterised	5 mg is far below the level at which blood pressure effects appear
Ashwagandha	A recognised, uncommon liver signal	Case series from two countries and a standing LiverTox monograph
L-arginine	Generally tolerated; digestive upset at gram doses	Those doses are far above anything an 82 mg blend can hold
Tribulus terrestris	Generally tolerated in the trials	The meta-analysis reported no difference in adverse events against placebo
Horny goat weed	Tolerated in traditional use; the concern is interaction	PDE5 activity is the reason, and it is a conversation rather than a warning

This table is about tolerance, not efficacy. Every row describes what is known about the plant, not about a share of an 82 mg blend, because nobody has studied that.

The label

The JellyFil label's own warning

Warning, as printed on the bottle

If you are pregnant or nursing, take medications or have a medical condition, consult your doctor before using. Discontinue use and consult your doctor if any adverse reactions occur.

That is the bottle speaking and it stays exactly as written. This desk's job is to make it specific rather than to repeat it: the medicines worth naming are nitrates, blood-pressure treatments and erectile-dysfunction prescriptions, and the conditions worth naming are liver disease and anything being managed with a medicine that is already hard on the liver.

If something goes wrong

What to do if something feels wrong on JellyFil

Stop taking it

The label says discontinue use and consult your doctor if any adverse reactions occur. That is the first step and it does not need this desk's permission.

Keep the bottle and the lot number

Lot JEL-26/JE-5655 is on this batch. A clinician asking what you took will want the panel, and the panel is on the bottle.

Tell the desk

+1 (507) 448-8190 for orders and refunds, contact@Jellyfile.com for anything about this website. A report that reaches us changes what these pages say.

Yellow eyes or skin, dark urine, unusual tiredness or pain under the right ribs are the specific things to take to a doctor quickly rather than to wait out, because those are the presentation the liver case series describe. Saying that once, precisely, is more use than a general caution repeated five times.

About this review

The safety record quoted on this JellyFil page

Dell'Agli M, Galli GV, Dal Cero E, et al. Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J Nat Prod. 2008;71(9):1513-7. Four plants traditionally used for impotence were screened against human PDE5A1. Only Epimedium and its icariin were active; Tribulus terrestris showed nothing. PMID 18778098. https://pubmed.ncbi.nlm.nih.gov/18778098/
Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. 2020;7:386-402. The review behind the cautionary labelling statement USP now recommends for green tea extract products. PMID 32140423. https://pubmed.ncbi.nlm.nih.gov/32140423/
Likhitsup A, Chen VL, Fontana RJ. Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults. JAMA Netw Open. 2024;7(8):e2425822. An estimated 15.6 million US adults had taken at least one in the past 30 days; green tea and ashwagandha are both on the list, and both are in this bottle. PMID 39102266. https://pubmed.ncbi.nlm.nih.gov/39102266/
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Green Tea. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda MD. The case record for green tea extract and liver injury, kept by NIDDK and free to read. https://www.ncbi.nlm.nih.gov/books/NBK547925/
Bjornsson HK, Bjornsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. PMID 31991029. https://pubmed.ncbi.nlm.nih.gov/31991029/
Philips CA, Valsan A, Theruvath AH, et al. Ashwagandha-induced liver injury-A case series from India and literature review. Hepatol Commun. 2023;7(10):e0270. PMID 37756041. https://pubmed.ncbi.nlm.nih.gov/37756041/
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ashwagandha. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda MD. https://www.ncbi.nlm.nih.gov/books/NBK548536/
Abbas-Hashemi SA, Hosseininasab D, Rastgoo S, et al. The effects of caffeine supplementation on blood pressure in adults: A systematic review and dose-response meta-analysis. Clin Nutr ESPEN. 2023;58:165-177. The diastolic effect appears above about 400 mg a day. PMID 38057002. https://pubmed.ncbi.nlm.nih.gov/38057002/
MedlinePlus. Caffeine. US National Library of Medicine, National Institutes of Health. The consumer page, including what counts as a high daily intake and who should keep it low. https://medlineplus.gov/caffeine.html
Brunetti P, Lo Faro AF, Tini A, et al. Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. Pharmaceuticals (Basel). 2020;13(10):309. Covers muira puama, maca, tribulus and horny goat weed together. PMID 33066617. https://pubmed.ncbi.nlm.nih.gov/33066617/
Suharyani S, Amanda B, Angellee J, et al. Tribulus terrestris for management of patients with erectile dysfunction: a systematic review and meta-analysis of randomized trials. Int J Impot Res. 2026;38(1):11-18. Eight trials: questionnaire scores beat placebo, and total testosterone did not differ between the groups. PMID 40360723. https://pubmed.ncbi.nlm.nih.gov/40360723/
Gonzales-Arimborgo C, Yupanqui I, Montero E, et al. Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study. Pharmaceuticals (Basel). 2016;9(3):49. 3 g a day for twelve weeks, with mood and energy as the outcomes that moved. PMID 27548190. https://pubmed.ncbi.nlm.nih.gov/27548190/
MedlinePlus Medical Encyclopedia. Sweeteners - sugars. US National Library of Medicine, National Institutes of Health. Background for the 3 g of added sugar this gummy carries. https://medlineplus.gov/ency/article/002444.htm

Who writes the JellyFil pages, and where the numbers come from

This desk sells the bottle and also writes about it. That is a conflict of interest, and naming it first is cheaper than being caught by it, so the working rule here is that nothing gets printed which a reader cannot go and check. The bottle artwork supplies the panel, the routine and the count, and the panel is reproduced on this website exactly as it is printed, including the three plants the advertising leaves out. It supplies one figure for the whole blend and no figure for any single plant, and none is invented to fill the space: what sits there instead is the amount each published trial gave people, lifted out of the record it belongs to and linked straight back to it. Spotted something wrong? contact@Jellyfile.com reaches the people who wrote it, the page changes, and the date below moves with it. Last reviewed September 2026.

Three more pages

Where to read further about JellyFil

Who is JellyFil for?The five groups who should not buy it, and why. JellyFil ingredientsEach plant, with the dose every trial used. JellyFil Supplement FactsThe panel, the warning and the storage line in full.

JellyFil bottles, front label, 30 gummies

Two questions before the first JellyFil gummy

One about nitrates and ED prescriptions, one about the liver. Both are short and both are worth asking before you pay rather than after.

From $158 for two bottles to $294 for six, with 60 days on all three

Choose A JellyFil Pack

Chewed, one a day, 30 to a bottle. Batch JEL-26/JE-5655, shipped from the United States.